DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per ordinary share. The dividend is payable on August 19, 2011, to shareholders of record on August 1, 2011.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Bruce Farmer, 508-452-4372
Coleman Lannum, CFA, 508-452-4343
Todd Carpenter, 508-452-4363
KEYWORDS: United States Europe North America New York Ireland
INDUSTRY KEYWORDS: Health Biotechnology Medical Devices Pharmaceutical Medical Supplies